Avricore Health (AVCRF) Short-term Investments (2009 - 2025)

Avricore Health has disclosed Short-term Investments across 10 years of filings, most recently posting $237691.3 for Q3 2022.

• In Q3 2022, Short-term Investments fell 3.48% year-over-year to $237691.3; the TTM figure through Sep 2022 stood at $237691.3 (down 3.48% YoY), while the FY2021 annual figure was $247366.2, up 3213.77% from the prior year.
• Short-term Investments declined to $237691.3 in Q3 2022, from $243145.6 in the prior quarter.
• Over the last five years, Short-term Investments for AVCRF reached as high as $252193.4 in Q2 2021 and fell as low as $7212.0 in Q2 2020.
• The 5-year median for Short-term Investments is $12836.8 (2018), against an average of $110813.7.
• Annual changes were most pronounced in 2020 — Short-term Investments sank 43.06% — and 2021, when it soared 3396.84%.
• A 5-year view of Short-term Investments shows it stood at $12840.1 in 2018, then decreased by 1.35% to $12667.0 in 2019, then tumbled by 39.44% to $7670.5 in 2020, then surged by 3106.21% to $245934.2 in 2021, then slipped by 3.35% to $237691.3 in 2022.
• According to Business Quant data, Short-term Investments over the past three periods registered $237691.3, $243145.6, and $244737.4 for Q3 2022, Q2 2022, and Q1 2022 respectively.